These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 33390845)

  • 1. Long Non-Coding RNAs: Potential Biomarkers and Targets for Hepatocellular Carcinoma Therapy and Diagnosis.
    Yuan D; Chen Y; Li X; Li J; Zhao Y; Shen J; Du F; Kaboli PJ; Li M; Wu X; Ji H; Cho CH; Wen Q; Li W; Xiao Z; Chen B
    Int J Biol Sci; 2021; 17(1):220-235. PubMed ID: 33390845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Long Non-Coding RNA and microRNA Networks in Hepatocellular Carcinoma and Its Tumor Microenvironment.
    Shi T; Morishita A; Kobara H; Masaki T
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNAs as biomarkers and therapeutic targets: Recent insights into hepatocellular carcinoma.
    Qiu L; Tang Q; Li G; Chen K
    Life Sci; 2017 Dec; 191():273-282. PubMed ID: 28987633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum exosomal long noncoding RNAs lnc-FAM72D-3 and lnc-EPC1-4 as diagnostic biomarkers for hepatocellular carcinoma.
    Yao Z; Jia C; Tai Y; Liang H; Zhong Z; Xiong Z; Deng M; Zhang Q
    Aging (Albany NY); 2020 Jun; 12(12):11843-11863. PubMed ID: 32554864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of serum lncRNA-uc003wbd and lncRNA-AF085935 expression profile in patients with hepatocellular carcinoma and HBV.
    Lu J; Xie F; Geng L; Shen W; Sui C; Yang J
    Tumour Biol; 2015 May; 36(5):3231-6. PubMed ID: 25501706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long noncoding RNAs PVT1 and uc002mbe.2 in sera provide a new supplementary method for hepatocellular carcinoma diagnosis.
    Yu J; Han J; Zhang J; Li G; Liu H; Cui X; Xu Y; Li T; Liu J; Wang C
    Medicine (Baltimore); 2016 Aug; 95(31):e4436. PubMed ID: 27495068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma HULC as a promising novel biomarker for the detection of hepatocellular carcinoma.
    Xie H; Ma H; Zhou D
    Biomed Res Int; 2013; 2013():136106. PubMed ID: 23762823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of long noncoding RNAs expression profile as potential serum biomarkers in patients with hepatocellular carcinoma.
    Kamel MM; Matboli M; Sallam M; Montasser IF; Saad AS; El-Tawdi AHF
    Transl Res; 2016 Feb; 168():134-145. PubMed ID: 26551349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy.
    Hou W; Bonkovsky HL
    World J Gastroenterol; 2013 Nov; 19(44):7836-45. PubMed ID: 24307777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LINC01225 promotes occurrence and metastasis of hepatocellular carcinoma in an epidermal growth factor receptor-dependent pathway.
    Wang X; Zhang W; Tang J; Huang R; Li J; Xu D; Xie Y; Jiang R; Deng L; Zhang X; Chai Y; Qin X; Sun B
    Cell Death Dis; 2016 Mar; 7(3):e2130. PubMed ID: 26938303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. lncRNA-D16366 Is a Potential Biomarker for Diagnosis and Prognosis of Hepatocellular Carcinoma.
    Chao Y; Zhou D
    Med Sci Monit; 2019 Sep; 25():6581-6586. PubMed ID: 31475695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating LncRNAs Serve as Diagnostic Markers for Hepatocellular Carcinoma.
    Yuan W; Sun Y; Liu L; Zhou B; Wang S; Gu D
    Cell Physiol Biochem; 2017; 44(1):125-132. PubMed ID: 29130980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma.
    Zeng YL; Guo ZY; Su HZ; Zhong FD; Jiang KQ; Yuan GD
    World J Gastroenterol; 2019 Dec; 25(48):6902-6915. PubMed ID: 31908394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic utility of plasma lncRNA small nucleolar RNA host gene 1 in patients with hepatocellular carcinoma.
    Gao S; Xu X; Wang Y; Zhang W; Wang X
    Mol Med Rep; 2018 Sep; 18(3):3305-3313. PubMed ID: 30066898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of long non coding RNA genes is associated with expression with polymorphisms of HULC rs7763881 and MALAT1 rs619586 in hepatocellular carcinoma and HBV Egyptian patients.
    Motawi TMK; El-Maraghy SA; Sabry D; Mehana NA
    J Cell Biochem; 2019 Sep; 120(9):14645-14656. PubMed ID: 31009106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of long noncoding RNA and c-JUN expression in hepatocellular carcinoma.
    El-Tawdi AH; Matboli M; El-Nakeep S; Azazy AE; Abdel-Rahman O
    Expert Rev Gastroenterol Hepatol; 2016 Jul; 10(7):869-77. PubMed ID: 27215316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of long noncoding RNAs in hepatocellular carcinoma.
    Huang Z; Zhou JK; Peng Y; He W; Huang C
    Mol Cancer; 2020 Apr; 19(1):77. PubMed ID: 32295598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNAs in hepatocellular carcinoma: Ordering of the complicated lncRNA regulatory network and novel strategies for HCC clinical diagnosis and treatment.
    Li C; Yang J; Liu C; Wang X; Zhang L
    Pharmacol Res; 2020 Aug; 158():104848. PubMed ID: 32389858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNAs in hepatocellular carcinoma: Potential roles and clinical implications.
    Niu ZS; Niu XJ; Wang WH
    World J Gastroenterol; 2017 Aug; 23(32):5860-5874. PubMed ID: 28932078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.